PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FAD8U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $28,028
Award facts
- Contract value 100% obligated
- $28,028.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $28,028 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 15, 2025, with an ultimate completion date of December 16, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The awardee, AmerisourceBergen Drug Corp, is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, which serves as the place of performance. This delivery order is a child contract awarded under a larger vehicle and represents one of numerous federal procurements through which the company supplies pharmaceutical products and medical supplies to support military and veteran healthcare systems.
AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999, running through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support program enabling the company to supply a broad range of pharmaceuticals, medical supplies, vaccines, and specialty medications to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates extensive experience fulfilling medical procurement requirements across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. The DLA is planning next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen Drug Corp among the critical vendors serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2D826FAD8U?
SPE2D826FAD8U was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on December 15, 2025.
How much is contract SPE2D826FAD8U worth?
The government has obligated $28,028 on SPE2D826FAD8U.
Is contract SPE2D826FAD8U an order under another contract?
Yes. SPE2D826FAD8U is a delivery order under SPE2DX22D0099, an indefinite delivery contract.
Was contract SPE2D826FAD8U competed?
The extent of competition for SPE2D826FAD8U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award